<DOC>
	<DOCNO>NCT00140023</DOCNO>
	<brief_summary>The study assess clinical efficacy Day 14-21 ( Test Cure ) , 14-21 day start study drug ; subject baseline pathogen identify also assess bacteriologic response . All subject receive 1 dose study medication assess safety .</brief_summary>
	<brief_title>Azithromycin Microspheres Patients With Low Risk Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<criteria>Male female , 18 year age old , oral , outpatient therapy indicate . Diagnosis CAP manifest least 3 follow : cough , pleuritic chest pain , fever ( temperature &gt; 37.8 C &lt; 40 C ) , auscultatory finding pulmonary examination rale and/or evidence pulmonary consolidation , dyspnea , tachypnea , laboratory result elevate total peripheral white blood count ( WBC &gt; 10,000/mm3 great 15 % immature neutrophil ( band ) Known suspect hypersensitivity intolerance azithromycin macrolides . Previously diagnose disease ( ) immune function , include : subject baseline absolute neutrophil count &lt; 1,000/mm3 , HIV positive subject CD4 count &lt; 200 cells/mm3 , immunoglobin neutrophil disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>